D-erythro-Sphingosine-C20

• CAT Number: R061868
• CAS Number: 6918-49-6
• Molecular Formula: C20H41NO2
• Molecular Weight: 327.55
• Purity: ≥95%
• Synonyms: (E)-D-erythro-2-Amino-4-eicosene-1,3-diol; [R-[R*,S*-(E)]]-2-Amino-4-eicosene-1,3-diol; C20-Sphingosine; D-erythro-1,3-Dihydroxy-2-amino-trans-4-eicosene; Eicosaphingenine; Gangliosphingosine; (2S,3R,E)-2-Aminoicos-4-ene-1,3-diol
• Storage: -20°C
• IUPAC Name: (E,2S,3R)-2-aminoicos-4-ene-1,3-diol
• InChI: InChI=1S/C20H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)19(21)18-22/h16-17,19-20,22-23H,2-15,18,21H2,1H3/b17-16+/t19-,20+/m0/s1
• InChIKey: HTJSZHKGNMXZJN-YIVRLKKSSA-N
• SMILES: CCCCCCCCCCCCCCCC=CC(C(CO)N)O

D-erythro-Sphingosine-C20(CAT: R061868) is a long-chain base sphingolipid, specifically a variant of sphingosine with a 20-carbon chain. Sphingosines are key components of sphingolipids, which are vital to cellular membrane structure and signaling pathways. This specific form, D-erythro-Sphingosine-C20, plays an important role in cellular processes such as apoptosis, cell differentiation, and inflammatory responses. It serves as a precursor to complex sphingolipids and is involved in the formation of bioactive molecules like ceramides, which regulate various biological functions. Researchers study D-erythro-Sphingosine-C20 for its involvement in lipid metabolism, neurobiology, and its potential as a target in disease treatments, particularly in cancer and neurodegenerative disorders.